ИСТИНА

• Охват: Международная
• Даты проведения: 24-26 мая 2022
• Место проведения: Москва, Russia
• Организатор:
  Институт биомедицинской химии
• Число участников: 500
• Число иностранных участников: 100
• Число докладчиков: 500
• Веб-сайт: http://way2drug.com/dr/bcadd2022/cv/BCADD-XXVIII-Symposium-Proceedings-Book-2022.pdf
• Описание конференции:

  This Symposium is dedicated to the emerging challenges and opportunities for in silico drug discovery. The Symposium's main topics: development and practical application of computational methods for finding and validation of new pharmacological targets, in silico design of potent and safe pharmaceutical agents, optimization of the structure and properties of drug-like compounds, rational approaches to the utilization of pharmacotherapeutic remedies in medical practice. This information will be useful for researchers whose investigations are dedicated to creating computational methods and their application to drug research and development using bio- and chemoinformatics methods based on post-genomic technologies. It can also be useful for undergraduate, graduate, and postgraduate students specializing in the relevant fields

• Добавил в систему: Новоселецкий Валерий Николаевич

Доклады:

• 2022 ACTIVITY PREDICTION OF SARS-COV-2 MPRO INHIBITORS BASED ON ENSEMBLE DOCKING AND MACHINE LEARNING (Устный)
• Авторы: Fomina Anastasia D., Osolodkin Dmitry I.

• 2022 AFFINITY PREDICTION OF PROTEIN COMPLEXES FROM STRUCTURE-BASED FEATURES USING GRADIENT BOOSTING (Стендовый)
• Авторы: Tychinin D.I., Shaitan K.V., Novoseletsky V.N.

• 2022 New inhibitors of the coagulation factor XIIa: Docking and experimental verification (Устный)
• Авторы: Tashchilova A.S., Sulimov A.V., Kutov D.C., Ilin I.S., Potapov A.Yu, Vandyshev D.Yu, Shikhaliev Kh S., Podoplelova N.A., Panteleev M.A., Sulimov V.B.

• 2022 Study of the early stage structural rearrangement of H3N2 influenza virus hemagglutinin subunit HA2 during fusion with a host cell (Устный)
• Авторы: Podshivalov D.D., Kirilin E.M., Konnov S.I., Švedas V.K.

• 2022 Synthesis, docking, and in vitro anticoagulant activity assay of rhodanine derivatives of pyrrolo[3,2,1-ij]quinolin-2(1h)-one as new inhibitors of factor Xa and factor XIa (Устный)
• Авторы: Tashchilova A., Novichikhina N., Shestakov A., Ilin I., Sulimov V., Panteleev M., Podoplelova N.

• 2022 The Philosophy And Prospects Of Fragment Contribution Estimations In Drug Discovery (Устный)
• Авторы: Shulga Dmitry A., Ivanov Nikita N., Palyulin Vladimir A.